Janus Henderson Investors US’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-75,600	Closed	-$5.76M	–	1162
2016 Q4	$5.76M	Sell	75,600 -36,300	-32%	-$2.76M	﹤0.01%	819
2016 Q3	$9.33M	Buy	111,900 +11,000	+11%	+$922K	0.01%	707
2016 Q2	$8.32M	Sell	100,900 -300	-0.3%	-$24.7K	0.01%	693
2016 Q1	$7.68M	Buy	101,200 +61,900	+158%	+$4.58M	0.01%	705
2015 Q4	$3.16M	Sell	39,300 -51,000	-56%	-$3.68M	﹤0.01%	880
2015 Q3	$5.74M	Buy	90,300 +14,200	+19%	+$1.02M	0.01%	808
2015 Q2	$5.35M	Buy	76,100 +51,500	+209%	+$3.81M	﹤0.01%	790
2015 Q1	$1.95M	Sell	24,600 -36,100	-59%	-$2.66M	﹤0.01%	906
2014 Q4	$3.86M	Buy	60,700 +8,800	+17%	+$552K	﹤0.01%	837
2014 Q3	$3.1M	Sell	51,900 -107,500	-67%	-$6.15M	﹤0.01%	855
2014 Q2	$8.53M	Buy	159,400 +79,700	+100%	+$4.37M	0.01%	704
2014 Q1	$4.81M	Buy	+79,700	New	+$4.65M	﹤0.01%	776
2013 Q4	–	Sell	-6,300	Closed	-$291K	–	1078
2013 Q3	$291K	Sell	6,300 -64,400	-91%	-$2.96M	﹤0.01%	1029
2013 Q2	$2.9M	Buy	+70,700	New	+$3.03M	﹤0.01%	781